Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Oogenesis
Gene-Environment Interactions
Major Hormones and Their Functions
Drug Dosing: Obese Patients
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 23, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Retha R Newbold1, Elizabeth Padilla-Banks, Wendy N Jefferson
1Developmental Endocrinology and Endocrine Disruptor Section, Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, NIH, DHHS, Research Triangle Park, NC 27709, United States. newbold1@niehs.nih.gov
Developmental exposure to environmental estrogens can disrupt endocrine pathways, leading to later-life health issues like obesity and diabetes. This research highlights the link between environmental estrogens and these diseases, emphasizing prevention during critical developmental periods.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: